2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole

C206H130N22O4 — CID 158617740

IUPAC2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cc(-c9ccccc9)cc(-c9ccccc9)c8)c67)o5)cccc43)c2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cccc(-c9ccccc9)c8)c67)o5)cccc43)c2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cccc(-c9ccccc9)n8)c67)o5)cccc43)n2)cc1.c1cncc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cccc(-c9cccnc9)n8)c67)o5)cccc43)n2)c1
InChIInChI=1S/C62H40N4O.C50H32N4O.C48H30N6O.C46H28N8O/c1-5-19-41(20-6-1)45-35-46(42-21-7-2-8-22-42)38-49(37-45)65-57-33-16-14-28-53(57)59-54(30-18-34-58(59)65)61-63-64-62(67-61)55-31-17-29-52-51-27-13-15-32-56(51)66(60(52)55)50-39-47(43-23-9-3-10-24-43)36-48(40-50)44-25-11-4-12-26-44;1-3-15-33(16-4-1)35-19-11-21-37(31-35)53-45-29-10-8-24-41(45)47-42(26-14-30-46(47)53)49-51-52-50(55-49)43-27-13-25-40-39-23-7-9-28-44(39)54(48(40)43)38-22-12-20-36(32-38)34-17-5-2-6-18-34;1-3-15-31(16-4-1)38-24-13-29-43(49-38)53-41-27-10-8-20-35(41)45-36(22-12-28-42(45)53)47-51-52-48(55-47)37-23-11-21-34-33-19-7-9-26-40(33)54(46(34)37)44-30-14-25-39(50-44)32-17-5-2-6-18-32;1-3-20-38-31(13-1)32-15-5-17-35(44(32)54(38)42-24-8-19-37(50-42)30-12-10-26-48-28-30)46-52-51-45(55-46)34-16-6-22-40-43(34)33-14-2-4-21-39(33)53(40)41-23-7-18-36(49-41)29-11-9-25-47-27-29/h1-40H;1-32H;1-30H;1-28H
InChIKeyHXPGNCPRIMOHKP-UHFFFAOYSA-N
MW2977.46 g/mol
LogP51.43
Rot. Bonds26

About 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole

2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole (PubChem CID 158617740) has the molecular formula C206H130N22O4 and a molecular weight of 2977.46 g/mol. Its IUPAC name is 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole
PubChem CID158617740
Molecular FormulaC206H130N22O4
Molecular Weight2977.46 g/mol
Exact Mass2975.06
IUPAC Name2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cc(-c9ccccc9)cc(-c9ccccc9)c8)c67)o5)cccc43)c2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cccc(-c9ccccc9)c8)c67)o5)cccc43)c2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cccc(-c9ccccc9)n8)c67)o5)cccc43)n2)cc1.c1cncc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cccc(-c9cccnc9)n8)c67)o5)cccc43)n2)c1
InChIInChI=1S/C62H40N4O.C50H32N4O.C48H30N6O.C46H28N8O/c1-5-19-41(20-6-1)45-35-46(42-21-7-2-8-22-42)38-49(37-45)65-57-33-16-14-28-53(57)59-54(30-18-34-58(59)65)61-63-64-62(67-61)55-31-17-29-52-51-27-13-15-32-56(51)66(60(52)55)50-39-47(43-23-9-3-10-24-43)36-48(40-50)44-25-11-4-12-26-44;1-3-15-33(16-4-1)35-19-11-21-37(31-35)53-45-29-10-8-24-41(45)47-42(26-14-30-46(47)53)49-51-52-50(55-49)43-27-13-25-40-39-23-7-9-28-44(39)54(48(40)43)38-22-12-20-36(32-38)34-17-5-2-6-18-34;1-3-15-31(16-4-1)38-24-13-29-43(49-38)53-41-27-10-8-20-35(41)45-36(22-12-28-42(45)53)47-51-52-48(55-47)37-23-11-21-34-33-19-7-9-26-40(33)54(46(34)37)44-30-14-25-39(50-44)32-17-5-2-6-18-32;1-3-20-38-31(13-1)32-15-5-17-35(44(32)54(38)42-24-8-19-37(50-42)30-12-10-26-48-28-30)46-52-51-45(55-46)34-16-6-22-40-43(34)33-14-2-4-21-39(33)53(40)41-23-7-18-36(49-41)29-11-9-25-47-27-29/h1-40H;1-32H;1-30H;1-28H
InChIKeyHXPGNCPRIMOHKP-UHFFFAOYSA-N
XLogP51.43
TPSA272.46 Ų
H-Bond Donors
H-Bond Acceptors26
Rotatable Bonds26
Heavy Atoms232
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002977.46
LogP ≤ 551.43
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1026

Analyze 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole?
The IUPAC name of 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole (CID 158617740) is 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole?
The canonical SMILES for 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole is c1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cc(-c9ccccc9)cc(-c9ccccc9)c8)c67)o5)cccc43)c2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cccc(-c9ccccc9)c8)c67)o5)cccc43)c2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cccc(-c9ccccc9)n8)c67)o5)cccc43)n2)cc1.c1cncc(-c2cccc(-n3c4ccccc4c4c(-c5nnc(-c6cccc7c8ccccc8n(-c8cccc(-c9cccnc9)n8)c67)o5)cccc43)n2)c1.
What is the InChIKey of 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole?
The InChIKey is HXPGNCPRIMOHKP-UHFFFAOYSA-N. The full InChI is InChI=1S/C62H40N4O.C50H32N4O.C48H30N6O.C46H28N8O/c1-5-19-41(20-6-1)45-35-46(42-21-7-2-8-22-42)38-49(37-45)65-57-33-16-14-28-53(57)59-54(30-18-34-58(59)65)61-63-64-62(67-61)55-31-17-29-52-51-27-13-15-32-56(51)66(60(52)55)50-39-47(43-23-9-3-10-24-43)36-48(40-50)44-25-11-4-12-26-44;1-3-15-33(16-4-1)35-19-11-21-37(31-35)53-45-29-10-8-24-41(45)47-42(26-14-30-46(47)53)49-51-52-50(55-49)43-27-13-25-40-39-23-7-9-28-44(39)54(48(40)43)38-22-12-20-36(32-38)34-17-5-2-6-18-34;1-3-15-31(16-4-1)38-24-13-29-43(49-38)53-41-27-10-8-20-35(41)45-36(22-12-28-42(45)53)47-51-52-48(55-47)37-23-11-21-34-33-19-7-9-26-40(33)54(46(34)37)44-30-14-25-39(50-44)32-17-5-2-6-18-32;1-3-20-38-31(13-1)32-15-5-17-35(44(32)54(38)42-24-8-19-37(50-42)30-12-10-26-48-28-30)46-52-51-45(55-46)34-16-6-22-40-43(34)33-14-2-4-21-39(33)53(40)41-23-7-18-36(49-41)29-11-9-25-47-27-29/h1-40H;1-32H;1-30H;1-28H.
What are the key properties of 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole?
2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole has a molecular weight of 2977.46 g/mol, XLogP of 51.43, 26 rotatable bonds, 0 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[9-(3,5-diphenylphenyl)carbazol-1-yl]-5-[9-(3,5-diphenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(3-phenylphenyl)carbazol-1-yl]-5-[9-(3-phenylphenyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-phenyl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-phenyl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole;2-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-1-yl]-5-[9-(6-pyridin-3-yl-2-pyridinyl)carbazol-4-yl]-1,3,4-oxadiazole is sourced from PubChem (CID 158617740), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).